trending Market Intelligence /marketintelligence/en/news-insights/trending/U5Ao0Q0wzawRMLYGsx--fw2 content esgSubNav
In This List

BioScrip-Option Care merger receives shareholder approval

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


BioScrip-Option Care merger receives shareholder approval

BioScrip Inc. has received shareholder approval of its proposed merger with fellow healthcare provider Option Care Enterprises Inc. at an Aug. 2 stockholder meeting.

The all-stock deal, announced in March, is on track to close Aug. 6, Denver-based BioScrip said in a press release.

The transaction, which will allow the combined company to cover 96% of the U.S. population with its home and alternate site infusion services, has already received U.S. antitrust clearance.